<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-162870</identifier>
<setSpec>2173-2345</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Osteoporosis in rheumatic diseases and glucocorticoid induced</dc:title>
<dc:description xml:lang="en">Osteoporosis is a systemic skeletal disease characterized by low bone mineral density, changes in bone microarchitecture and increased risk of fracture. It has been shown that depends on physiological processes and secondary to other pathologies and associated with the use of glucocorticoids, the latest being the most common cause of osteoporosis associated to drugs, this may be represent a great magnitude public health issue. This review is presented in order to emphasize the clinical importance of osteoporosis in rheumatic diseases and glucocorticoid-induced osteoporosis (AU)</dc:description>
<dc:creator>Maldonado, G</dc:creator>
<dc:creator>Messina, O</dc:creator>
<dc:creator>Moreno, M</dc:creator>
<dc:creator>Ríos, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La osteoporosis es una enfermedad esquelética sistémica caracterizada por disminución de la densidad mineral ósea con alteraciones de la microarquitectura del hueso y aumento del riesgo de fractura. Se ha demostrado que depende de procesos fisiológicos y secundarios a otras patologías como son las enfermedades reumáticas, e incluso asociado al uso de glucocorticoides siendo esta la causa más frecuente de osteoporosis asociada a fármacos, y que a su vez representa una problemática de gran magnitud en la actualidad. Debido a esto, se presenta esta revisión con el fin de recalcar la importancia clínica de la osteoporosis en las enfermedades reumáticas e inducidas por glucocorticoides (AU)</dc:description>
<dc:source>Rev. osteoporos. metab. miner. (Internet);9(1): 38-49, ene.-mar. 2017. tab, ilus</dc:source>
<dc:identifier>ibc-162870</dc:identifier>
<dc:title xml:lang="es">Osteoporosis en enfermedades reumáticas e inducidas por glucocorticoides</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d15208^s22073</dc:subject>
<dc:subject>^d28302^s22080</dc:subject>
<dc:subject>^d10188^s22021</dc:subject>
<dc:subject>^d10205^s22036</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28261^s22073</dc:subject>
<dc:subject>^d50518^s22012</dc:subject>
<dc:subject>^d24543^s22021</dc:subject>
<dc:subject>^d13552^s22012</dc:subject>
<dc:subject>^d28302^s22036</dc:subject>
<dc:subject>^d1178^s22036</dc:subject>
<dc:subject>^d1178^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201703</dc:date>
</metadata>
</record>
</ibecs-document>
